Skip to main content
. 2023 Jul 28;24:100546. doi: 10.1016/j.lana.2023.100546

Table 1.

Baseline characteristics of patients meeting high-risk criteria as observed in electronic medical records.

Already diagnosed Newly diagnosed Undiagnosed
Cohort totalsa, n 54,580 16,012 40,202
Age by index date, mean (SD) 68.7 (10.6) 67.1 (11.1) 63.6 (11.9)
Female, n (% of cohort) 31,821 (58.3) 9406 (58.7) 24,437 (60.8)
Race and Ethnicity, n (% of cohort)
 White 42,553 (78.0) 12,346 (77.1) 28,642 (71.2)
 Black 5083 (9.3) 1552 (9.7) 9117 (22.7)
 Other Races/Not recorded 5992 (11) 1798 (11.2) 1982 (5)
 Hispanic 952 (1.7) 316 (2) 461 (1.1)
Smoking, n (% of cohort)
 Current Smoker 16,069 (29.4) 5141 (32.1) 6668 (16.6)
 Ex-Smoker 19,257 (35.3) 4734 (29.6) 27,316 (67.9)
Clinically diagnosed comorbidities (ever), n (% of cohort)
 Diabetes type 2 16,499 (30.2) 4699 (29.3) 11,523 (28.7)
 Osteoporosis 7404 (13.6) 1602 (10) 2893 (7.2)
 Hypertension 34,571 (63.3) 9266 (57.9) 25,491 (63.4)
 Chronic kidney disease 8194 (15) 2146 (13.4) 4665 (11.6)
 Depression/Anxiety 25,713 (47.1) 885 (22.2) 30,142 (28.5)
 Congestive Heart Disease 19,968 (36.6) 4799 (30) 9943 (24.7)
 Obstructive Sleep Apnea 9942 (18.2) 2260 (14.1) 10,097 (25.1)
 Gastroesophageal reflux disease (GERD) 22,293 (40.8) 5336 (33.3) 13,333 (33.2)
 Anemia 12,163 (22.3) 3020 (18.9) 6858 (17.1)
Major cardiac events, n (% of cohort) 5289 (9.7) 1542 (9.6) 3140 (7.8)
BMI recorded within 5 years of index date, n (% of cohort)
 Underweight (<18.5) 1963 (3.6) 444 (2.8) 309 (0.8)
 Normal weight (18.5–24) 12,907 (23.6) 3409 (21.3) 6171 (15.3)
 Overweight (25–29) 14,657 (26.9) 4160 (26) 11,159 (27.8)
 Obese (30.0+) 22,493 (41.2) 6760 (42.2) 21,822 (54.3)
 Missing BMI 3113 (5.7) 1222 (2.4) 1069 (2.0)
a

See Supplementary Table S4 for further baseline characteristics.